Related references
Note: Only part of the references are listed.The Value of Liquid Biopsies for Guiding Therapy Decisions in Non-small Cell Lung Cancer
Jatta Saarenheimo et al.
FRONTIERS IN ONCOLOGY (2019)
FGFR1 Cooperates with EGFR in Lung Cancer Oncogenesis, and Their Combined Inhibition Shows Improved Efficacy
Alvaro Quintanal-Villalonga et al.
JOURNAL OF THORACIC ONCOLOGY (2019)
Periodic Limb Movements During Sleep Noted on Ventral Thigh Surface Electromyography in an Above-the-Knee Amputated Stump
Aditya Chada et al.
JOURNAL OF CLINICAL SLEEP MEDICINE (2019)
Genomic Profiling of Driver Gene Mutations in Chinese Patients With Non-Small Cell Lung Cancer
Hongxue Meng et al.
FRONTIERS IN GENETICS (2019)
The Factors Predicting Concordant Epidermal Growth Factor Receptor (EGFR) Mutation Detected in Liquid/Tissue Biopsy and the Related Clinical Outcomes in Patients of Advanced Lung Adenocarcinoma with EGFR Mutations
Chia-Yu Kuo et al.
JOURNAL OF CLINICAL MEDICINE (2019)
Efficacy comparison of targeted next-generation sequencing in the identification of somatic mutations in circulating tumor DNA from different stages of lung cancer
Y. Chen et al.
NEOPLASMA (2019)
Comparison of plasma ctDNA and tissue/cytology-based techniques for the detection of EGFR mutation status in advanced NSCLC: Spanish data subset from ASSESS
E. Arriola et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2018)
Correlation of Somatic Genomic Alterations Between Tissue Genomics and ctDNA Employing Next-Generation Sequencing: Analysis of Lung and Gastrointestinal Cancers
Omer M. Toor et al.
MOLECULAR CANCER THERAPEUTICS (2018)
Heterogeneous mutation pattern in tumor tissue and circulating tumor DNA warrants parallel NGS panel testing
Qiaomei Guo et al.
MOLECULAR CANCER (2018)
The 8th lung cancer TNM classification and clinical staging system: review of the changes and clinical implications
Wanyin Lim et al.
QUANTITATIVE IMAGING IN MEDICINE AND SURGERY (2018)
Maftools: efficient and comprehensive analysis of somatic variants in cancer
Anand Mayakonda et al.
GENOME RESEARCH (2018)
A Pilot Study to Non-Invasively Track PIK3CA Mutation in Head and Neck Cancer
Henri Schmidt et al.
DIAGNOSTICS (2018)
Lung cancer in never smokers-the East Asian experience
Fei Zhou et al.
TRANSLATIONAL LUNG CANCER RESEARCH (2018)
Non-blood circulating tumor DNA detection in cancer
Muyun Peng et al.
ONCOTARGET (2017)
Treating KRAS-mutant NSCLC: latest evidence and clinical consequences
Pilar Garrido et al.
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY (2017)
A Phase Ib Open-Label Multicenter Study of AZD4547 in Patients with Advanced Squamous Cell Lung Cancers
Paul K. Paik et al.
CLINICAL CANCER RESEARCH (2017)
Targeting the KRAS variant for treatment of non-small cell lung cancer: potential therapeutic applications
Biagio Ricciuti et al.
EXPERT REVIEW OF RESPIRATORY MEDICINE (2016)
Routine molecular profiling of patients with advanced non-small-cell lung cancer: results of a 1-year nationwide programme of the French Cooperative Thoracic Intergroup (IFCT)
Fabrice Barlesi et al.
LANCET (2016)
Circulating cell-free DNA as a prognostic and predictive biomarker in non-small cell lung cancer
Bo Ai et al.
ONCOTARGET (2016)
KRAS mutations in the circulating free DNA (cfDNA) of non-small cell lung cancer (NSCLC) patients
Monica Garzon et al.
TRANSLATIONAL LUNG CANCER RESEARCH (2016)
FGFR1 amplification in lung squamous cell carcinoma: A systematic review with meta-analysis
Tao Jiang et al.
LUNG CANCER (2015)
Co-occurring Genomic Alterations Define Major Subsets of KRAS-Mutant Lung Adenocarcinoma with Distinct Biology, Immune Profiles, and Therapeutic Vulnerabilities
Ferdinandos Skoulidis et al.
CANCER DISCOVERY (2015)
Survival outcome according to KRAS mutation status in newly diagnosed patients with stage IV non-small cell lung cancer treated with platinum doublet chemotherapy
Anna K. Brady et al.
ONCOTARGET (2015)
PIK3CA mutations in non-small cell lung cancer (NSCLC): Genetic heterogeneity, prognostic impact and incidence of prior malignancies
Matthias Scheffler et al.
ONCOTARGET (2015)
FGFR1 mRNA and Protein Expression, not Gene Copy Number, Predict FGFR TKI Sensitivity across All Lung Cancer Histologies
Murry W. Wynes et al.
CLINICAL CANCER RESEARCH (2014)
Using Multiplexed Assays of Oncogenic Drivers in Lung Cancers to Select Targeted Drugs
Mark G. Kris et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2014)
An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage
Aaron M. Newman et al.
NATURE MEDICINE (2014)
Lung cancer molecular epidemiology in China: recent trends
Caicun Zhou
TRANSLATIONAL LUNG CANCER RESEARCH (2014)
ALK Rearrangements Are Mutually Exclusive with Mutations in EGFR or KRAS: An Analysis of 1,683 Patients with Non-Small Cell Lung Cancer
Justin F. Gainor et al.
CLINICAL CANCER RESEARCH (2013)
New Targetable Oncogenes in Non-Small-Cell Lung Cancer
Geoffrey R. Oxnard et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Implementing multiplexed genotyping of non-small-cell lung cancers into routine clinical practice
L. V. Sequist et al.
ANNALS OF ONCOLOGY (2011)
EGFR Mutations and Lung Cancer
Gilda da Cunha Santos et al.
ANNUAL REVIEW OF PATHOLOGY: MECHANISMS OF DISEASE, VOL 6 (2011)
SurvJamda: an R package to predict patients' survival and risk assessment using joint analysis of microarray gene expression data
Haleh Yasrebi
BIOINFORMATICS (2011)
Erlotinib versus chemotherapy as first-line treatment for patients with advanced EGFR mutation-positive non-small-cell lung cancer (OPTIMAL, CTONG-0802): a multicentre, open-label, randomised, phase 3 study
Caicun Zhou et al.
LANCET ONCOLOGY (2011)
Spectrum of Oncogenic Driver Mutations in Lung Adenocarcinomas from East Asian Never Smokers
Chenguang Li et al.
PLOS ONE (2011)
Potential Clinical Significance of a Plasma-Based KRAS Mutation Analysis in Patients with Advanced Non-Small Cell Lung Cancer
Shuhang Wang et al.
CLINICAL CANCER RESEARCH (2010)
Gefitinib or Carboplatin-Paclitaxel in Pulmonary Adenocarcinoma.
Tony S. Mok et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
PIK3CA mutation status in Japanese lung cancer patients
Osamu Kawano et al.
LUNG CANCER (2006)
Mechanisms of Disease: oncogene addiction - a rationale for molecular targeting in cancer therapy
I. Bernard Weinstein et al.
NATURE CLINICAL PRACTICE ONCOLOGY (2006)
The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism
Jeffrey A. Engelman et al.
NATURE REVIEWS GENETICS (2006)
High frequency of coexistent mutations of PIK3CA and PTEN genes in endometrial carcinoma
K Oda et al.
CANCER RESEARCH (2005)
Detection and quantification of mutations in the plasma of patients with colorectal tumors
F Diehl et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
High frequency of mutations of the PIK3CA gene in human cancers
Y Samuels et al.
SCIENCE (2004)
EGF receptor gene mutations are common in lung cancers from never smokers and are associated with sensitivity of tumors to gefitinib and erlotinib
W Pao et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Share Paper
